CoVerage

CoVerage continuously predicts and characterizes emerging potential SARS-CoV-2 Variants of Interest from country-wise lineage frequency dynamics together with their antigenic and evolutionary alterations.

Key Features:

• Genomic Surveillance: CoVerage continuously monitors viral genome sequence data from the GISAID viral genome resource to detect emerging variants.
• Variant Prediction: CoVerage predicts potential Variants of Interest based on country-wise lineage frequency dynamics with a lead time of almost three months relative to WHO designation.
• Antigenic Characterization: CoVerage characterizes variants by analyzing antigenic alterations alongside evolutionary changes.
• Evolutionary Analysis: CoVerage assesses evolutionary alterations of predicted variants to understand their phenotypic potential.

Scientific Applications:

• SARS-CoV-2 Variant Detection: CoVerage identifies and characterizes Variants of Concern, Variants Under Monitoring, and Variants of Interest relevant for public health.
• Vaccine Efficacy Assessment: CoVerage supports the evaluation of SARS-CoV-2 variants that may affect vaccine efficacy through antigenic change analysis.
• Public Health Management: CoVerage facilitates timely identification and assessment of SARS-CoV-2 variants to optimize pandemic response strategies.

Methodology:

CoVerage analyzes viral genome sequence data from GISAID and applies computational methods to country-wise lineage frequency dynamics to predict and characterize emerging potential Variants of Interest.